» Articles » PMID: 7561985

PEAPS-Q: a Questionnaire to Measure the Psychosocial Effects of Having an Abnormal Pap Smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire

Overview
Publisher Elsevier
Specialty Public Health
Date 1995 Oct 1
PMID 7561985
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed the Psychosocial Effects of Abnormal Pap Smears Questionnaire (PEAPS-Q) which measures distress experienced by women undergoing follow-up investigation after an abnormal Pap smear result. A thorough literature review and qualitative research resulted in the development of a questionnaire which was tested on 350 women attending a Family Planning New South Wales (FPNSW) clinic. This sample included women at different stages of management after detection of a cervical abnormality: 93 first colposcopy clients and 257 follow-up colposcopy clients. Factor analysis identified four dimensions of distress: experience of medical procedures, beliefs/feelings about cervical abnormality and changes in perception of oneself, worry about infectivity and effect on sexual relationships. Repeatability of the PEAPS-Q was indicated by intra-class correlations of 0.88 overall and at least 0.60 for each scale. Internal consistency was shown by Cronbach's alpha of 0.84 overall and at least 0.72 for each scale. Validity was demonstrated by the correlation of scale scores with the 12-item General Health Questionnaire (GHQ) score of 0.32 (95% CI 0.22-0.41). The PEAPS-Q is a valid, reliable and multidimensional instrument for quantifying distress experienced by women with abnormal Pap smears.

Citing Articles

Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study.

Liang L, Zeissig S, Schauberger G, Merzweiler S, Radde K, Fischbeck S BMC Womens Health. 2022; 22(1):285.

PMID: 35810270 PMC: 9270801. DOI: 10.1186/s12905-022-01851-6.


Development and psychometric properties of the human papillomavirus-quality of life (HPV-QoL) questionnaire to assess the impact of HPV on women health-related-quality-of-life.

Coronado P, Gonzalez-Granados C, Ramirez-Mena M, Calvo J, Fasero M, Bellon M Arch Gynecol Obstet. 2022; 306(4):1085-1100.

PMID: 35551456 PMC: 9470626. DOI: 10.1007/s00404-022-06583-4.


Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey.

Chadwick V, Bennett K, McCaffery K, Brotherton J, Dodd R Psychooncology. 2022; 31(7):1110-1119.

PMID: 35128756 PMC: 9546150. DOI: 10.1002/pon.5897.


Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.

Bennett K, Waller J, McBride E, Forster A, Di Gessa G, Kitchener H BJOG. 2020; 128(4):745-754.

PMID: 32783300 PMC: 8432156. DOI: 10.1111/1471-0528.16460.


Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.

Stuart A, Obiri-Yeboah D, Adu-Sarkodie Y, Hayfron-Benjamin A, Akorsu A, Mayaud P BMC Womens Health. 2019; 19(1):123.

PMID: 31647013 PMC: 6813105. DOI: 10.1186/s12905-019-0818-y.